Providers
This activity is provided by The France Foundation
Grant Support
This activity is supported by an educational grant from Insmed.
Credits Available
- Physicians—maximum of 1.0 AMA PRA Category 1 Credit(s)™
- PAs—maximum of 1.0 AAPA Category 1 CME credit
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for pulmonologists and other clinicians caring for patients with bronchiectasis.
Program Overview
Bronchiectasis is complex, often underdiagnosed, and frequently misunderstood. Explore key contributors to disease progression, including the role of neutrophilic inflammation and neutrophilic serine proteases, and learn to distinguish bronchiectasis from other respiratory conditions and assess patient risk factors that impact outcomes. This module covers how pulmonary exacerbations influence disease course and highlights new insights from recent clinical trials. Stay ahead of the curve with updates on emerging therapies that could transform how we manage this challenging disease.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the role of neutrophilic inflammation and neutrophil serine proteases in the pathophysiology of bronchiectasis
- Summarize the natural history of bronchiectasis, including associated patient risk factors and the impact of pulmonary exacerbations on disease progression
- Differentiate bronchiectasis from other respiratory conditions, such as asthma and COPD, to help achieve an early and accurate diagnosis
- Assess the latest clinical trial results for emerging therapies in the treatment of bronchiectasis
Faculty
Christopher J. Richards, MD
Instructor of Medicine
Harvard Medical School
Boston, MA
Ashley J. Losier, MD
Instructor of Medicine
Yale Medical School
New Haven, CT
Accreditation Statement
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid through August 30, 2026. PAs should only claim credit commensurate with the extent of their participation.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflict of Interest
- Christopher Richards, MD , Planning Committee Member, Faculty. No relevant financial disclosures
- Ashley Losier, MD, Planning Committee Member, Faculty, ElectroMed, Inc. (Smartvest), Insmed, Inc., Advisory Board. These relationships have ended
- Patrick Harty, PhD, TFF Content Reviewer, No relevant financial disclosures
- Miriam Giles, TFF Staff, No relevant financial disclosures
- Amanda Noe, TFF Staff, No relevant financial disclosures
Instructions for Participation and Credit
There are no fees for participating in and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling.
This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Disclaimer
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.
Contact Information
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or [email protected].